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There is growing evidence that air pollution increases the incidence of asthma in 
both children and adults. The association between air pollution and asthma has 
been investigated in many studies which have shown this relationship considering 
respiratory symptoms and hospitalizations. This retrospective study was 
conducted on a sample of patients resident in the metropolitan area of Parma; 
249 patients, with asthma diagnosis according to the international guidelines, 
were selected among those who have carried out at least two visit at the Asthma 
outpatient Clinic of Parma University Hospital,  from January 2008 to March 2012 . 
For every day in which an examination took place  were registered the 
concentrations of PM10, NO2 and benzene. In addition to the general data, for 
every patient has been collected information about asthma familiarity, atopy, BMI 
and the possible therapy carried out in the indicated period during the 
examinations. Regarding the respiratory conditions of patients during every 
examination, these tests were taken into consideration: Asthma Control test (a 
test performed by patients to evaluate the pathology grade during the month 
prior to the test), the fraction of exhaled nitric oxide (FeNO) measurement as an 
inflammatory index of the airways and some values taken in the spirometric 
examination. In particular The forced vital capacity (FVC), forced expiratory 
volume in the first second (FEV 1 ), FEV 1 /FVC ratio, forced expiratory flow rate 
over the middle 50% of the FVC (FEF 25–75 ) and FEF25-75/FVC were recorded. 
The sample has been studied considering both the changes of the respiratory 
parameters for every patient in their examinations, and the respiratory 
parameters of all the examinations took as a whole in relation with the pollutants’ 
variations. Although many confounding factors presence makes difficult to 
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evaluate atmospheric pollution importance on the breathing functionalities 
variation, measured by objective test, the results show that FVC and FEV1 
decreases are statistically significant in relation to higher PM10 values in non-
therapy subjects, similar to the changes observed in NO2 and benzene high values 
presence. 
Considering consider each subject control of himself, spirometric tests worse in 
relation  to higher pollutant concentration and particularly, reach statistical 
significance in relation to NO2 and benzene increases. 
Finally, if we only consider steroid  therapy, in quartiles analysis, it results more 
evident the FVC% and FEV% variations both for PM10 and NO2 and benzene, while 
the analysis on each individual patient, small airway parameters seem to be more 
influenced by NO2 and benzene higher values.   
In conclusion, our results provided the evidence that the environmental exposure 
may be an additional risk factor which should be considered in the assessment of 
the asthmatic patients. 
 
 
 
 
 
 
6 
 
Numerose evidenze mostrano come l’inquinamento atmosferico aumenti 
l’incidenza dell’asma sia nei  bambini che negli adulti. L’associazione tra 
inquinamento atmosferico e asma è stata investigata in molti studi i quali hanno 
messo in evidenza questa relazione considerando i sintomi respiratori e i ricoveri 
ospedalieri. Questo studio retrospettivo è stato condotto su un campione di 
pazienti residenti nell’area metropolitana di Parma. Sono stati selezionati 249 
pazienti tra quelli che hanno svolto almeno due visite di controllo presso 
l’Ambulatorio dell’Asma della Clinica Pneumologica dell’Ospedale Universitario di 
Parma nel periodo che va da Gennaio 2008 a Marzo 2012. Per ogni giorno in cui si 
è svolta una visita, sono state registrate le concentrazioni degli inquinanti: PM10, 
NO2 e Benzene. Oltre ai dati generali per ogni paziente sono state raccolte una 
serie di informazioni quali la presenza o meno di familiarità per l’asma, l’atopia e 
l’eventuale terapia svolta nel periodo delle visite considerate. Mentre per quanto 
riguarda lo stato respiratorio dei pazienti nelle diverse visite sono stati 
considerati: l’Asma Control Test (un test svolto dal paziente per valutare lo stato 
della patologia durante il mese precedente il test), la misurazione dell’ossido 
nitrico esalato (FeNO) quale indice di infiammazione delle vie aeree, e alcuni valori 
osservati nell’esame spirometrico; in particolare la capacità vitale forzata (FVC), il 
volume espiratorio forzato nel primo secondo (FEV), l’indice di Tiffeneau 
(FEV1/FVC), il flusso espiratorio forzato al 50% dell’FVC (FEF25-75) e il rapporto 
FEF25-75/FVC. Il campione è stato studiato sia considerando i cambiamenti dei 
parametri respiratori di ogni singolo paziente nelle diverse visite, sia considerando 
i parametri respiratori nella totalità delle visite come campione messo in relazione 
con le variazioni degli inquinanti. Sebbene la presenza di numerosi fattori di 
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confondimento renda difficile stimare il peso dell’inquinamento atmosferico sulle 
variazioni della funzionalità respiratoria misurata attraverso test oggettivi, i 
risultati mostrano che sono statisticamente significative le diminuzioni di FVC e 
FEV1 in relazione a valori più elevati di PM10 in soggetti non in terapia, simili alle 
variazioni osservate in presenza di valori elevati  di NO2 e di Benzene. 
Considerando ogni soggetto come controllo di se stesso, i test spirometrici 
peggiorano in relazione alle concentrazioni più elevate di inquinante, in 
particolare raggiungono la significatività statistica in relazione all’NO2 e al 
Benzene. Infine se si considera esclusivamente la terapia steroidea, risultano, 
nell’analisi sui quartili, più evidenti le variazioni di FVC e FEV1 sia per il PM10 che 
per l’NO2 che per il Benzene mentre nell’analisi su ogni singolo paziente i 
parametri delle piccole vie sembrano risentire maggiormente dei valori più elevati 
di NO2 e di Benzene. 
In conclusione i nostri risultati hanno dimostrato che l’esposizione ambientale può 
essere un fattore di rischio aggiuntivo che dovrebbe essere considerato nella 
valutazione della popolazione asmatica. 
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Air pollution significantly contributes to the global burden of disease [1]. The 
effects of the air pollution on human health have been known for years, in 
particular for the huge impact on health of some severe episodes of pollution 
between 1930-1950. London case in 1952, known as “The Great Smog of London” 
was emblematic: from the fifth to the eight of December, thanks also to the 
presence of particular meteorological conditions, London was wrapped up in a 
smog (= smoke + fog) blanket. It was an hard winter and people have burned huge 
quantity of coal to heat their homes, causing the emission of many pollutant 
substances in the atmosphere: the concentrations of sulphur dioxide (SO2) and 
total suspended particulate exceeded the daily average of 2000 μg/m3, with peaks 
during the day until 5000 μg/m3. In the week affected by the phenomenon it was 
assessed an excess of nearly 4000 deaths with a case prevalence between 
children, elderly and subjects with cardio circulatory and respiratory diseases. 
Deaths were due to respiratory insufficiency, acute bronchitis and pneumonia 
increased 9.3 times compared with the same period in the year before [12]. It is 
clear that the urban environment is particularly interested by the air pollution; 
indeed many human pollutant activities here occur in a confined space and the 
population is more exposed to mixtures of physical and chemical agents 
potentially harmful for the human health. The attention should be given mainly to 
pollutants produced by car traffic, domestic heating and industrial plants. Growing 
evidences show that it is possible to ascribe to the exposition of environmental 
pollutant quotes not negligible of the morbidity and mortality for neoplasms    
[13-15], cardiovascular and respiratory diseases [2-5,11]. Hospital admissions of 
patients with chronic obstructive pulmonary disease (COPD) [6-10] or asthma are 
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more frequent during the periods of acute increase in air pollution. In particular 
asthma higher prevalence in socio-economic developed countries [16] and the 
difference in prevalence rates between the urban and rural areas [17,18] has led 
to think that, although genetic predisposition is an essential factor in determining 
atopy and bronchial hyperactivity [31], for the onset and the course of the disease 
the environmental factors like cigarette smoking [31], occupational allergens [31] 
and air pollution [19,20] are determinant. There is growing evidence that air 
pollution increases the incidence of asthma in both children [21,24] and adults 
[19,22,23]. The association between air pollution and asthma has been 
investigated in many studies which have shown this relationship considering 
respiratory symptoms [25-27] and hospitalizations [27-30].  Epidemiologic studies 
have importantly  contributed to our understanding of the role of air pollution as 
a risk factor for respiratory disease. In addition, epidemiologic studies, especially 
those with large populations suitable for population health inference, have 
become increasingly important as the basis for policies, standards, and 
regulations. 
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ENVIRONMENTAL POLLUTION 
DEFINITION 
The environmental pollution was defined by the Italian legislation on air quality, 
with the DPR 203/88, as: “every modification in the composition or physic state of 
atmospheric air due to the presence of one or more substances in quantity and 
with certain characteristics such as to alter the normal environmental condition 
and the air healthiness, to pose a danger or injury directly or indirectly for the 
human health, compromising recreational activities and the others legitimate uses 
of the environment, to alter the biological resources, ecosystems and public and 
private asset.” [32]. These substances, which cause a measurable effect on living 
organisms or on different materials, are often absent in the normal composition 
of air or they are present at a lower concentration. The pollution which they 
create don’t develop only in the external environments (outdoor pollution) but 
also in confined settings, such as buildings (indoor pollution). The possibilities that 
pollutants could react lead to discriminate between: 
- Primary pollutant: pollutants which are emitted directly in the atmosphere from 
the sources without any other modifications; the main primary pollutants are 
those emitted by combustion processes of any kind, e.g. not combusted 
hydrocarbon, carbon monoxide, nitrogen oxides (mainly monoxides). 
- Secondary pollutant: pollutants which are created in the atmosphere following 
chemical-physical transformations of many substances which can be primary 
pollutants or not. Among the formation processes of secondary pollutants, the 
series of reactions between nitrogen oxides and hydrocarbons with solar light are 
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particularly important. This reaction chain lead for example to the oxidation of 
nitrogen monoxide (NO) which create nitrogen dioxide (NO2) and to the 
production of ozone (O3). All the products of these reactions are defined as 
photochemical smog which represent one of the most dangerous forms of 
pollution for the ecosystem. 
Another way to classify the pollutants is to distinguish them by their origin: 
natural or anthropic. There are many sources of natural air pollutant however 
they don’t represent a serious problem such as those generated by human 
activities because they often result less dangerous of the compounds produces by 
human beings. The natural sources of sulfur dioxide include volcanoes, organic 
decomposition and forest fire. The natural sources of nitrogen oxides include 
volcanoes, oceans, organic decompositions and lighting action. Ozone is a 
secondary pollutant that is created close to the ground as a result of chemical 
reactions catalyzed by the light. Anyway nearly 10-15% of ozone comes from the 
higher layer of the atmosphere (stratosphere) where it’s created from the 
molecular oxygen with the action of UV rays. The importance of the natural 
sources of particulate is smaller than the anthropogenic sources because they 
originate particles with dimensions not dangerous for the breathing apparatus. In 
this category are included volcanoes and sandstorms. These sources usually don’t 
cause severe episodes of pollution because the pollution takes place in a limited 
period. Many volatile organic compounds (VOC) are produced by plants, for 
example isoprene is a common VOC produced by vegetation. Moreover plants 
produce pollen (which is considered a component of the atmospheric particulate) 
and everybody knows the allergic effect that they can cause in predisposed 
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subjects. Other natural pollutants of great importance in confined environments 
(indoor) are mold spores and dust in general. Since less could be done by humans 
towards natural pollution, the main concern must be to reduce the pollution 
emitted by human activities. The major atmospheric pollution is the one that man 
produce to satisfy his own civil and industrial need. The several combustion 
processes used to cook food, to heat, to start motor vehicles and machinery, 
create the most prevailing pollutants. Air pollution of anthropogenic origin is 
emitted by the great stable sources (industries, plants for the production of 
electric energy and incinerators); by small stable sources (plants for the domestic 
heating) and by mobile sources (vehicular traffic). Many of these sources are 
strictly linked to the production and consume of energy, especially fossil fuel. The 
use of fossil fuels for the domestic heating, in particular heavy fuel oil, biomass 
and coal is a significant origin of environmental pollution, particulate and sulfur 
dioxide. Even traffic contribute to the emissions of these pollutants in cities where 
there is a great traffic congestion. Combustions generally represent the principal 
cause for the nitrogen oxide emissions; the engines of the means of transport are 
the principal cause for the emissions of carbon monoxide. In addition to all these 
substances produced by the combustion processes there are all the pollutants 
originated by particular technological cycles. These compounds are released in 
considerably low quantities and for this reason they are little relevant to a 
planetary level; nevertheless they have often a high toxicity and their presence is 
very important at a local level. The impact of the pollutant on human beings 
depends on the production area and on their dispersion. Great stable sources, 
localized mainly far away from great urban centers, waste the pollutants in the air 
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at great height while domestic heating and traffic waste theirs close to the ground 
in densely inhabited areas. As a result, mobile and small stable sources contribute 
in a major way to the air pollution in urban areas so they are a greater threat for 
the human health than what could be expected making a simple quantitative 
comparison among the different types of emissions. 
The concentration of pollutant in the atmosphere is determined not only by the 
number and the intensity of the pollution sources, by the distance from those 
sources and by the chemical-physical transformation to which they are subjected 
but especially by the meteorological conditions which constitute the key 
parameter for the comprehension of the origin, the entity and the development in 
time of an event of atmospheric pollution. In general, in the presence of the same 
emissions of pollutants from the sources, the concentrations in the air are lower 
with precipitations, with moderate or high wind or when the wind is gentle or 
absent but there is a strong sunstroke with blue sky and the sun is high in the sky. 
Vice versa, the concentrations become high with light wind or with persistent fog 
that provokes accumulation processes. In association with meteorological 
conditions even the orographic conformation of the territory affects the air 
quality we breath, i.e. the particular conformation of Po valley, closed to the north 
by the Alps and to the south by Apennines, creates a climatic condition more 
stagnant than other European regions. In this area the pollutant substances 
remain for prolonged periods, for this reason there is an aggravation of the 
pollutant values. 
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PRINCIPAL POLLUTANTS AND THEIR EFFECTS 
 
PARTICULATE 
Physical-chemical characteristics 
With the term PM, particulate matter, is defined a complex mixture of organic and 
inorganic substances in the solid or liquid state which, due to their small 
dimensions, remain suspended in the atmosphere for longer or shorter periods of 
time. The particles have a dimension between 0,005 µm and 50-150 µm; they are 
made of a mixture of substances like sulphate, niter, ammonia, carbon, organic 
compounds, soil fragments, sea salts, metals and radical compound. Particulate is 
generally distinct in four dimensional class: 
- TSP (total suspended particles): these particles have dimensions above 10 µm; 
- PM 10: particulate made of particles with a diameter lower than 10 µm (Figure 1); 
- PM 2.5: thin particulate made of particles with a diameter lower than 2,5 µm 
(Figure 1); 
- PM 0,1 or ultrathin: particulate with a diameter lower or equal to 0,1 µm. 
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Sources 
The particulate sources could be natural or anthropic. 
Natural sources 
- Sea aerosol 
- Fire 
- Microorganisms 
- Pollen and spores 
- Rocks erosion 
- Volcano eruptions 
Anthropic sources 
- Engine combustion emissions (trucks, cars, planes, boats) 
- Domestic heating emissions (particularly diesel oil, coal and wood) 
- Residues of the use of the pavement, brakes and tires 
- Emissions of industrial plants 
- Incinerators and electric plants 
- Farm production (use of fertilizers) 
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Permanence and removal time 
The permanence time varies between few minutes to days depending on the 
dimensions of the particulate and the atmospheric layer interested. The 
particulate could be transported for long distances. Its removal could be achieved 
by the gravitational sedimentation of the particles  and the aggregation with other 
particles (dry mode) or by precipitations (wet mode). 
Health effects  
The pollution due to PM10 cause damaging effects to the human health both in 
the short (acute effects) and in the long period (chronic effects). Its 
dangerousness is strictly linked to its composition because the particles, due to 
their particular superficial structure, could adsorb acid and chemical carcinogenic 
substances from the air. The toxic action of PM10 is performed mainly on the 
breathing apparatus and the relevant factor to study the effects is the particles 
dimension because the ability to penetrate in the apparatus depends on this 
characteristic (Figure 2). The greater particles (with a diameter above 10 µm), in 
this context called inhalable fraction, penetrate in the respiratory tract until the 
nasopharyngeal area where they are filtered and blocked. When the particles 
reach the nose-laryngeal area they can be eliminated violently by a simple sneeze 
but in some cases they can reach the posterior zone of the pharynx and then they 
can be swallowed. The particles with a diameter lower than 10 µm called thoracic 
fraction are able to pass the extra thoracic tract (nasal cavities, pharynx and 
larynx) reaching easily the tracheal-bronchial area. The particles with a diameter 
between 2,5 and 3,3 µm stop before reaching the bronchioles. Finally, the 
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particles with a diameter lower than 2,5 µm reach the alveolar area penetrating in 
the alveoli if their diameter is lower than 1 µm. Nowadays there is a great interest 
in the fraction of particulate represented by ultrathin particles because their size 
is the reason why they can propagate in all the respiratory tract, walk in the cells 
and by that to pass the epithelial and endothelial walls. The specific contribute of 
ultrathin particles to the toxicity in humans is under study with toxicological and 
epidemiological approaches [33]. 
The most exposed people are elderly and subjects with preexisting cardiovascular 
pathologies [34], asthmatic [36], people that carry out an intense physical activity 
outdoor and children [35] for their higher pulmonary ventilation for body weight 
unit and for the immaturity of their respiratory apparatus. 
 
SULFUR OXIDES (SOx) 
Chemical-physical characteristics 
In the atmosphere, both sulfur dioxide (SO2) and sulfur trioxide (SO3) are normally 
found. Sulfur dioxide is a colorless, irritating, not flammable, very soluble in water 
with a piquancy. It is heavier than air so it stratify in the lower areas. Sulfur 
dioxide tarnishes with a slow reaction to sulfur trioxide which, reacting with 
water, creates sulfuric acid responsible for acid rain. 
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Sources 
Sulfur dioxide is created mainly from combustion processes tarnishing sulfur 
which is present as an impurity in solid and liquid combustibles (carbon, fuel oil 
and diesel oil). The sources are the heating plants which works without methane, 
thermoelectric power plant, industrial combusting processes and the emissions 
coming from vehicles and maritime mean of transportation (Figure 3). 
Permanence and removal time 
The SO2 persists for several days. With particular meteorological conditions and in 
the presence of high value of emissions it can spread in the atmosphere, affecting 
even far territories. It is removed by rainfalls. 
Health effects 
The SO2 is highly soluble in water, for this reason it is easily adsorbed by the 
mucous of nose and the higher tract of the respiratory apparatus. The effects of 
low concentrations of sulfur dioxide are linked to pathologies of the respiratory 
apparatus like bronchitis, asthma and tracheitis but also irritation of skin, eyes and 
mucous [79]. The pathological effects  induced by SO2 appear when there are high 
levels of particulate because it can adsorb to the surface of them. Moreover the 
suspended dust are able to spread the pollutants to the deepest area in the 
respiratory apparatus. SO2 act an important role in the worsening of chronic 
pulmonary pathologies like asthma [37]. 
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NITROGEN OXIDES (NOx) 
Chemical-physical characteristics 
Nitrogen oxides (NOx) are present in the atmosphere, Nitrogen oxide or Nitrogen 
monoxide (NO) and Nitrogen dioxide (NO2) being the most important as 
atmospheric pollutants. 
Nitrogen monoxide is a gas which is colorless, flavorless and odorless; oxygen and 
ozone, which are present in the atmosphere, oxidize nitrogen monoxide thus 
creating nitrogen dioxide. The toxicity of nitrogen monoxide is very low contrary 
to that of nitrogen dioxide which result considerably high. Nitrogen dioxide is a 
toxic gas with a yellow-red color, a piquancy, and a strong irritating and oxidizing 
power. The well-known yellowish color of mist which cover the cities with high 
traffic is due precisely to nitrogen dioxide. Although it is considered a secondary 
pollutant because it originate from the oxidation of nitrogen monoxide, the 
Nitrogen dioxide constitutes the intermediate to create other secondary 
pollutants like ozone, nitric acid, nitrous acid, alkyl nitrate, peroxyacetyl nitrate 
(PAN) and others which are responsible for the formation of photochemical smog. 
Sources 
Nitrogen oxides exists in nature in moderate concentrations, independently from 
the pollution. The natural sources are constituted basically by anaerobic organic 
decompositions which reduce nitrate to nitrite. The great part of Nitrogen oxides 
(mostly Nitrogen monoxide) is emitted by high-temperature combustion 
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processes like those produced in vehicular engines. The high temperatures start a 
reaction between oxygen and nitrogen contained in the air creating Nitrogen 
monoxide. The amount of the compound produced is higher the higher is the 
combusting temperature and the faster is the cooling of these gases. Nitrogen 
monoxide emitted by exhaust gases is oxidized by the oxygen present in the air 
with the formation of Nitrogen dioxide. In general diesel engines emit more 
Nitrogen oxides and particulate than petrol engines but the second one emit more 
Carbon monoxide and hydrocarbon. Among the sources of Nitrogen oxides are 
thermal plants and thermoelectric power plants (the amounts emitted however 
are low because during the combustion the flame temperature is low), the 
production of nitrogenous fertilizers, the production of nitric acid coming from the 
oxidation of ammonia, the manufacture of explosives and the chemical processes 
which implies nitric acid. 
Permanence and removal time 
Nitrogen oxides remain in the atmosphere nearly for 4-5 day. They are removed 
as a consequence of chemical reactions which create acids, with aqueous vapor, 
or organic substances, with hydrocarbons and radicals.  
Effects on health 
Nitrogen dioxide is a mucous-irritating gas responsible of many alterations of the 
pulmonary functions, chronic bronchitis [63] and asthma [19]. Prolonged 
exposition to this compound, even at low concentrations, provokes a severe 
decrease of pulmonary defenses resulting in an increase of respiratory 
pathologies [80]. 
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OZONE (O3) 
Chemical-physical characteristics 
Ozone is a bluish toxic gas constituted by instable molecules generated by three 
oxygen atoms (O3); these molecules splits easily releasing molecular oxygen and 
an extremely reactive oxygen atom (O3O2+O). Given those characteristics, 
Ozone is a strong oxidizer able to destroy organic and inorganic materials. 
Sources 
Ozone is present in the higher levels of the atmosphere (stratosphere), it has a 
natural origin and it is useful to protect from solar UV radiations. As a 
consequence of atmospheric circulation it is transported in small concentrations 
even to the lower levels of the atmosphere (troposphere) where it can also be 
produced by electric discharge during storms. The generation of huge 
concentration of ozone in the troposphere is mainly a summer phenomenon 
linked to the interaction between solar radiation and chemical substances 
(hydrocarbon and NO2) which, at high temperatures, start the chemical reactions 
producing O3, free radicals, peroxides and strong oxidizing substances. The 
sources of ozone “precursors” could be natural, like woods and forests which emit 
volatile organic compounds (COV), or anthropic, like vehicular engines, 
combustion processes, thermoelectric power plants and chemical solvent 
industries. 
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Permanence and removal time 
The ability to move with air masses far away from the source entails the presence 
of high concentration of Ozone at large distances; this determine the risk of 
significant expositions in people who live away from the principal sources of O3. 
Removal systems are strictly correlated to solar radiation and to the presence of 
precursors. 
Effects on health 
Increasing concentrations of ozone could cause irritation of the eyes, throat and 
respiratory apparatus. High concentrations cause cough, a chest tightness and 
dispnea. These concentrations can also lead to a decrease in the resistance to 
pulmonary bacterial infections, to the onset of respiratory apparatus pathologies 
and to the worsening of ongoing pathologies of respiratory (COPD, pneumonia, 
asthma [63] and pulmonary emphysema) and cardiac type (myocardium ischemia)  
CARBON MONOXIDE (CO) 
Chemical-physical characteristics 
Carbon oxide (CO) or carbon monoxide is a colorless, flavorless, inflammable and 
toxic gas. It creates from all those incomplete combustion processes which derives 
from an oxygen deficiency. In optimal conditions the carbon present in fuel 
combines with the oxygen in the air (combustive agent) and it is transformed in 
CO2 (carbon dioxide), according to the falling reaction: 
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C+O2 ⇋ CO2 (Combustion reaction with excess of oxygen) 
2C+O2 ⇋ 2CO (Combustion reaction with deficiency of oxygen) 
Sources 
The presence of carbon monoxide in the air we breathe is due to the human 
activity, however it must be considered also the amount due to natural emissions 
such as fires, volcanoes eruption, ocean and swamp emission and the oxidation of 
methane and hydrocarbons naturally emitted in the atmosphere. The main 
sources of anthropic origin is represented by exhaust gases, especially when the 
engines work at low speed with intense traffic. Other CO sources are the heating 
plants and some industrial processes like iron and cast iron production or the oil 
refining. 
Permanence and removal time 
Carbon monoxide is a primary pollutant for its long permanence in the 
atmosphere that could reach four-six months. For this reason it could be used as a 
marker for the temporal trend of primary pollutant at the ground level. 
Effects on health 
In normal conditions the oxygen breathed in passes blood to alveolar level and it 
binds to hemoglobin thus guaranteeing the oxygenation of tissues. The peculiar 
dangerousness of CO is due to the high affinity that this compound has in confront 
to hemoglobin; this affinity is nearly 220 times higher than oxygen affinity.  CO, 
once breathed in, binds to hemoglobin creating a compound, carboxyhemoglobin, 
which, contrary to hemoglobin, is physiologically inactive and it isn’t able to 
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guarantee the normal oxygenation of tissues provoking cellular anoxia. The most 
damaged organs are central nervous system and cardiovascular system, 
particularly in people with heart conditions. 
At low concentration CO causes headache, diffuse weakness, dizziness; at high 
concentration it causes death by asphyxiation, a problem well known in cases of 
malfunctioning of gas stoves. Nevertheless at the concentration normally 
detectable in the urban atmosphere the effects on health are reversible and less 
acute. 
 
BENZENE (C6H6) 
Chemical-physical characteristics 
Benzene (C6H6) is the basic compound in the category of aromatic hydrocarbons 
and its strong and sweetish smell make it recognizable even at low 
concentrations. At room temperature it is in a colorless liquid state and it vaporize 
quickly in the air. Although it is extremely flammable, its dangerousness is mainly 
due to the fact of being a carcinogen-recognized substance for humans. 
Sources 
The benzene present in the atmosphere derives both from natural source, like 
volcano eruption and forest fire, and from anthropic sources and the last one 
contributes mainly to the emissions. It Is a compound generated in consequence 
of the incomplete combustion of coal and oil; it is emitted by industries which use 
it in the production of plastic and polyesters. It is also present in the exhaust gases 
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of motor vehicles and it is emitted by some products in which it is contained such 
as glues, paints, furniture wax and detergent and together with cigarette smoke 
they are responsible for the exposure in closed environments. The traffic 
emissions are due to the evaporation of gasoline in tanks (5%) and mainly (95%) 
to the exhaust gases of gasoline vehicles, in fact to the gasoline it is added 
benzene, together with other aromatic compounds, to give the desired no 
explosive properties. The personnel of gas stations or of great warehouse is a 
worker category most exposed to high concentrations of this pollutant while 
tobacco smoke could be considered the main individual source of benzene for 
non-exposed population to this pollutant for professional reasons 
Permanence and removal time 
Given that Benzene is a very volatile compound, once it is released in the 
environment it splits preferentially in the air and since it is moderately soluble in 
water it could be removed from the atmosphere through wet depositions. The 
permanence of Benzene in the air depends from different factors among which 
the concentration of other pollutants, climatic conditions and its average lifetime 
which is variable from some hours to few days. 
Effects on health 
The exposure to Benzene may occur essentially by inhalation (nearly 99% of 
benzene), by cutaneous contact or by ingestion (consumption of contaminated 
food or beverage). The toxic effects caused by this organic compound present 
different characteristics and they damage different organs due to the exposure 
duration. Breathing air highly contaminated by benzene produce bedevilments, 
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tachycardia, headache, tremor and unconsciousness; high levels could be lethal. 
To eat or drink something contaminated by benzene could cause vomit, gastric 
wall irritation, drowsiness, convulsions, tachycardia and death. The chronic effects 
can regard respiratory disorders [24,68] but affect especially the blood cells and 
the organs that produce them like bone marrow. The effects appear in function of 
the dose of benzene to which a subject was exposed and they can vary from 
anemia to a simultaneous decrease of white blood cells and platelets. 
Epidemiological studies on humans, performed on professionally benzene-
exposed workers, suggest a myelotoxicity and leukemic activity [69]. 
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            LEGISLATIVE INTERVENTIONS 
Some pollutants no longer are a problem; for example carbon monoxide 
concentrations keep now low enough level and the ones of sulfur dioxide have 
been sensibly decreased thanks to industrial restructuration, technological 
innovations and use of low sulfur level combustible or of natural gas which has 
practically lack of it. Any excess is found instead for nitrogen oxides, but the real 
problem seems to be the one of fine powders.  In effect, in large part of Italian 
cities, particularly during winter season, it’s especially the PM10 concentrations 
that exceed the thresholds set out in the legislation. Then, actions are take as 
alternative car plates, traffic stop and restricted areas for most pollutant vehicles. 
These actions have surely the effect to temporally decrease pollutant outputs but 
not solve the problem. Same analysis should be done regarding ozone, another 
critical pollutant for our cities, particularly during summer season. That’s way air 
pollution is one of the most important European care.  From 70’s Europe searched 
to develop a air quality improvement policy basing on air pollutant vehicles 
outputs control and decrease; on combustible quality improvement and on 
integration of  atmospherically environment protection in all productive branches 
and human activities. Environment action European sixth program [72] 
(“Environment 2010: our future, our choice”) includes “Environment and health” 
subject as one of the most needed sector of urgent action; air pollution is one of 
the applications of Environment and Health theme and the goal of the 6st 
program is to reach air quality levels which generate acceptable protection levels 
for human health and environment.   In May 2008, a new 2008/50/EC Directive 
has been issued dated   May the 21 [70], regarding environment air quality and for 
31 
 
a purer air in Europe, which also present new goals concerning air quality and PM 
2,5 (thin powders  or breathable powders) adding the ones already published 
regarding PM10 (thoracic fraction powders). In Italy, European Directive have 
been received through DLGS 155/10 [71]where are been settled new air quality 
limits, reported under synthetic form in table 1. Dates reporting on this table must 
be interpreted basing on following instructions:    
 The limit value is a fixed level with goal to avoid negative health effects 
 Alarm limit is a level over which any exposure, even of short time, could generate 
health risk for all population so his attainment forces to take immediate 
measures. 
 Information limit is a level beyond which, although with short time exposures, 
there is health risk only for some sensible population groups and so, his 
attainment forces to take immediate information measures. 
 The target value is a security level to reach, where it’s possible, within 
determinate date. 
 Daily averages are hourly concentration averages during all day long 
 yearly averages are daily concentrations from January the 1st to December the 
31st 
 8 hours average is a mobile average calculated with a interval sliding on an same 
day 8 running hours 
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 3 hours average is a mobile average calculated with a interval sliding on a same 
day 3 running hours 
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HEALTH EFFECTS OF AIR POLLUTION  
Exposure to air pollution is associated with numerous effects on human health, 
including pulmonary, cardiac, vascular, and neurological impairments; they can be 
acute or short- term effects and chronic or long-term effects. Different groups of 
individuals are affected by air pollution in different ways. Some individuals are 
much more sensitive to pollutants than are others. The elderly and the people 
with health problems such as asthma [65] and chronic  bronchitis [66] or with 
cardiopulmonary disease, are the most vulnerable to air pollution exposure. Also 
the children are at greater risk because their lungs are still growing and they play 
outside and are active so they breathe more outdoor air pollution than most 
adults. The extent to which an individual is harmed by air pollution usually 
depends on the total exposure to the damaging chemicals: the duration of 
exposure, the concentration and the type of the chemicals must be taken into 
account.  
Acute effects are usually immediate and often reversible when exposure to the 
pollutant ends. Examples of short-term effects include irritation to the eyes, nose 
and throat, and upper respiratory infections such as bronchitis and pneumonia. 
Other symptoms can include headaches, nausea, and allergic reactions. Short-
term air pollution can aggravate the medical conditions of individuals with asthma 
and emphysema. Chronic effects are usually not immediate and tend not to be 
reversible when exposure to the pollutant ends. Long-term health effects can 
include chronic respiratory disease, lung cancer, heart disease, and even damage 
to the brain, nerves, liver, or kidneys. Continual exposure to air pollution affects 
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the lungs of growing children and may aggravate or complicate medical conditions 
in the elderly. 
Although in humans pollutants can affect the skin, eyes and other body systems, 
they affect primarily the cardio-respiratory system (Figure 4) . Air is breathed in 
through the nose, which acts as the primary filtering system of the body. The 
small hairs and the warm, humid conditions in the nose effectively remove the 
larger pollutant particles. Both gaseous and particulate air pollutants can have 
negative effects on the lungs. Solid particles can settle on the walls of the trachea, 
bronchi, and bronchioles. Most of these particles are removed from the lungs 
through the cleansing (sweeping) action of "cilia", small hair like outgrowths of 
cells, located on the walls of the lungs. This is what occurs when you cough or 
sneeze. 
A cough or sneeze transports the particles to the mouth. The particles are 
removed subsequently from the body when they are swallowed or expelled. 
However, extremely small particles may reach the alveoli, where it takes weeks, 
months, or even years for the body to remove the particles. Gaseous air pollutants 
may also affect the function of the lungs by slowing the action of the cilia. 
Continuous breathing of polluted air can slow the normal cleansing action of the 
lungs and result in more particles reaching the lower portions of the lung. The 
lungs are the organs responsible for absorbing oxygen from the air and removing 
carbon dioxide from the blood-stream. Damage to the lungs from air pollution can 
inhibit this process and contribute to the occurrence of respiratory diseases such 
as bronchitis, emphysema, and cancer [67]. This can also put an additional burden 
on the heart and circulatory system [67].  
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ASTHMA 
Asthma is defined by the Global Initiative for Asthma as "a chronic inflammatory 
disorder of the airways in which many cells and cellular elements play a role. The 
chronic inflammation is associated with airway hyper-responsiveness that leads to 
recurrent episodes of wheezing, breathlessness, chest tightness and coughing 
particularly at night or in the early morning. These episodes are usually associated 
with widespread, but variable airflow obstruction within the lung that is often 
reversible either spontaneously or with treatment" [38]. 
The inflammation of the airways makes them swollen, very sensitive and highly 
reactive to certain inhaled substances. When the airways react, the muscles 
around them tighten (Figure 5,6). This narrows the airways, causing less air to flow 
into the lungs and the classic symptoms of wheezing. Cells in the airways might 
make more mucus than usual (Figure 7). Mucus is a sticky, thick liquid that can 
further narrow the airways (Figure 7). Also another  typical changes in the airway 
include an increase in eosinophils and thickening of the lamina reticularis. 
Symptoms and exarcebation 
Asthma is characterized by recurrent episodes of wheezing, shortness of breath, 
chest tightness, and coughing [38]. Symptoms are often worse at night and in the 
early morning or in response to exercise or cold air [39]. Some people with asthma 
only rarely experience symptoms, usually in response to triggers, whereas others 
may have marked and persistent symptoms [38]. Some individuals will have stable 
asthma for weeks or months and then suddenly develop an episode of acute 
asthma with asthma attacks that can last for minutes to days, and can become 
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dangerous if the airflow is severely restricted. Different individuals react 
differently to various factors [41]. Most individuals can develop severe 
exacerbation from a number of triggering agents [41]. Psychological stress may 
worsen symptoms, it's thought that stress alters the immune system and thus 
increases the airway inflammatory response to allergens and irritants [42].  
Causes  
Asthma is caused by a combination of environmental and genetic factors [43]. 
These factors influence both its severity and how responsive it is to treatment.  
Many environmental factors have been associated with asthma's development 
and exacerbation including: allergens, air pollution, and other environmental 
chemicals. There is a relationship between exposure to air pollutants and the 
development of asthma [44]. Smoking during pregnancy and after delivery is 
associated with a greater risk of asthma-like symptoms [38]. Low air quality, from 
traffic pollution or high ozone levels has been associated with both asthma 
development and increase asthma severity [21-25,27,28,30]. Exposure to indoor 
volatile organic compounds may be a trigger for asthma; formaldehyde exposure, 
for example, has a positive association [46]. Also, phthalates in PVC are associated 
with asthma in children and adults [47,48] as are high levels of endotoxin 
exposure. Asthma is also associated with exposure to indoor [49] and outdoor 
allergens. Common indoor allergens include: dust mites, cockroaches, animal 
dander, and mold [50,51].  The most common outdoor allergens are pollen. Family 
history is a risk factor for asthma with many different genes being implicated [52]. 
By the end of 2005, 25 genes had been associated with asthma in six or more 
separate populations including: GSTM1, IL10, CTLA-4, SPINK5, LTC4S, IL4R and 
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ADAM33 among others [53]. Many of these genes are related to the immune 
system or to modulating inflammation. Even among this list of genes supported by 
highly replicated studies, results have not been consistent among all populations 
tested [53], in fact these studies are still in developing. The strongest risk factor 
for developing asthma is a history of atopic disease; with asthma occurring at a 
much greater rate in those who have either eczema or hay fever [38]. There is a 
correlation between obesity and the risk of asthma with both having increased in 
recent years [55,56]. Several factors may be at play including decreased 
respiratory function due to a buildup of fat and the fact that adipose tissue leads 
to a pro-inflammatory state [57].  
Diagnosis  
A diagnosis of asthma should be suspected if there is a history of: recurrent 
wheezing, coughing or difficulty breathing and these symptoms occur or worsen 
due to exercise, viral infections, allergens or air pollution. There are two  tests that 
can confirm the diagnosis: spirometry and methacoline challenge testing. 
Spirometry assesses lung function through different parameters, one of these is 
FEV1 (forced expiratory volume in one second) that is the volume of air you can 
breathe out in one second; if the FEV1 measured by this technique improves more 
than 12% following administration of a bronchodilator such as salbutamol this is 
supportive of the diagnosis. The methacoline challenge involves the inhalation of 
increasing concentrations of a substance that causes airway narrowing in those 
predisposed. If positive it’s possible establish the diagnosis of asthma. 
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Other supportive evidence includes: a ≥20% difference in peak expiratory flow 
rate on at least three days in a week for at least two weeks, a ≥20% improvement 
of peak flow following treatment with either salbutamol, inhaled corticosteroids 
or prednisone, or a ≥20% decrease in peak flow following exposure to a trigger 
[58]. Testing peak expiratory flow is more variable than spirometry, however, and 
thus not recommended for routine diagnosis. It may be useful for daily self-
monitoring in those with moderate to severe disease and for checking the 
effectiveness of new medications. It may also be helpful in guiding treatment in 
those with acute exacerbations.  
Management  
While there is no cure for asthma, symptoms can be improved. A specific, 
customized plan for proactively monitoring and managing symptoms should be 
created. This plan should include the reduction of exposure to allergens, testing to 
assess the severity of symptoms, and the usage of medications. The treatment 
plan should be written down and advise adjustments to treatment according to 
changes in symptoms.  
The most effective treatment for asthma is identifying triggers, such as cigarette 
smoke, air pollution or pets and eliminating exposure to them. If trigger avoidance 
is insufficient, the use of medication is recommended. Pharmaceutical drugs are 
selected based on, among other things, the severity of illness and the frequency of 
symptoms.  
Two types of asthma medications include short-acting, quick relief, medications 
and long-acting, controller, medications. Quick relief medications are used to treat 
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asthma symptoms when they occur. They relieve symptoms rapidly and are 
usually taken only when needed. Long-acting medications are preventative and 
are taken daily to help a patient achieve and maintain control of asthma 
symptoms. 
Bronchodilators are recommended for short-term relief of symptoms. In those 
with occasional attacks, no other medication is needed. If mild persistent disease 
is present (more than two attacks a week), low-dose inhaled glucocorticoids or 
alternatively, an oral leukotriene antagonist or a mast cell stabilizer is 
recommended. For those who have daily attacks, a higher dose of inhaled 
glucocorticoid is used. In a moderate or severe exacerbation, oral glucocorticoids 
are added to these treatments [59]. 
Epidemiology  
As of 2011, ~235 million people worldwide are affected by asthma, and 
approximately 250,000 people die per year from the disease [38]. Rates vary 
between countries with prevalence between 1 and 18% [38]. It is more common 
in developed than developing countries [38]. One thus sees lower rates in Asia, 
Eastern Europe and Africa [40]. Within developed countries it is more common in 
those who are economically disadvantage while in contrast in developing 
countries it is more common in the affluent [38]. The reason for these differences 
is not well know [38]. Low and middle income countries make up more than 80% 
of the mortality [45].  
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While asthma is twice as common in boys than girls [38], severe asthma occurs at 
equal rates [54]. In contrast adult women have a higher rate of asthma than men 
[38] and it is more common in the young than the old [40].  
Global rates of asthma have increased significantly between the 1960s and 2008 
[60] with it being recognized as a major public health problem since the 1970s 
[40]. Rates of asthma have stabilized in the developed world since the mid 1990s 
with recent increases primarily in the developing world. Asthma affects 
approximately 7% of the population of the United States [61] and 5% of people in 
the United Kingdom [62]. In Italy 11% of the population suffers from Bronchial 
Asthma. The figure emerged in the 110th Congress of the Italian Society of Internal 
Medicine. 
 
 
 
AIM OF THE STUDY 
The aim of the present study was to assess the effects of the changes of 
atmospheric pollutants on lung function parameters in a large cohort of asthmatic 
patients.  
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MATERIALS AND METHODS 
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Subjects 
The retrospective study was conducted on a sample of patients resident in the 
metropolitan area of Parma; 249 patients, with asthma diagnosis according to the 
international guidelines [31], were selected among those who have carried out at 
least two visits  at the Asthma outpatient Clinic of Parma University Hospital, in a 
period from January 2008 to March 2012.  
In addition to the general data, for every patient has been collected information 
about asthma familiarity, smoking habit, atopy, BMI and the possible therapy 
carried out in the indicated period during the examinations.  
BMI was defined as the weight in kilograms divided by the square of the height in 
meters; in each subject it was calculated from patients’ self-reported height and 
weight. Atopy was assessed by skin prick tests with a battery of 10 common 
inhalant allergens. Therapies normally taken by patients are bronchodilators and 
steroids. Regarding the respiratory conditions of patients during every 
examination, these tests were taken into consideration: Asthma Control test (a 
test performed by patients to evaluate the pathology grade during the month 
prior to the test), the fraction of exhaled nitric oxide (FeNO) measurement as an 
inflammatory index of the airways and some values taken in the spirometric 
examination. 
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FeNO MEASUREMENT 
 We ensured that the patients were not affected by any acute respiratory 
infection and had followed the pretest instructions, i.e. no nitrate-rich foods or 
beverages, including alcoholic ones, no tobacco smoking, and no exercise within 1 
h preceding the test, as these factors can affect the test results. Moreover, all 
patients underwent FeNO measurement before the lung function test. Only 
patients able to perform at least two acceptable FeNO measurements were 
included in the analysis. FeNO was measured according to American Thoracic 
Society/European Respiration Society (ATS/ERS) guidelines [74] using an FeNO 
stationary chemiluminescence analyzer (NIOX; Aerocrine AB, Solna, Sweden). All 
FeNO measurements were performed at the same time of day    (±2 h) to allow a 
possible circadian rhythm effect. Patients were seated in the upright position 
without a nose clip and were asked to inhale nitric oxide-free air through a filter 
connected to the device deeply to total lung capacity and then to exhale for 10s at 
a constant pressure guided by a visual cue to stabilize the flow rate. All tests were 
performed at an exhalation pressure of 10–20 cm H 2 O to maintain a fixed flow 
rate of 50 ml/s. Measurements were repeated after a brief rest period until two 
acceptable values ( ±2.5 ppb for measurements <50 ppb and ±5% for 
measurements ≥50 ppb) were obtained (maximum six attempts). The mean of 
two adequate values for each subject was recorded for analysis. The system 
calibration was performed every 14 days. 
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Asthma Control Assessment 
Asthma control was assessed using the Italian version of the ACT [75] . Patients 
subjectively evaluated the degree of impairment caused by their disease during 
the preceding 4 weeks by responding to five questions using a five-point scale. 
The ACT is reliable, valid, and responsive to changes in asthma control over time 
[75,76] . The sum of the scores of the five questions gave the total ACT score 
(range 0–25). A cut-off score of 19 or less identifies patients with poorly controlled 
asthma. 
Lung Function Testing 
Lung function was measured by a flow-sensing spirometer connected to a 
computer for data analysis (CPFS/D Spirometer; MedGraphics, St. Paul, Minn., 
USA) which met the ATS standards. 
The forced vital capacity (FVC), forced expiratory volume in the first second (FEV 1 
), FEV 1 /FVC ratio, forced expiratory flow rate over the middle 50% of the FVC 
(FEF 25–75 ) and FEF25-75/FVC [73] were recorded. FVC, FEV 1 and FEF 25–75 are 
expressed as  percents of predicted values [77], FEV 1 /FVC is expressed as a 
percent and FEF25-75/FVC is expressed as absolute values. 
Air quality measurement 
For every day in which an examination took place  were registered the 
concentrations of PM10, NO2 and benzene; were taken into account only those 
three pollutants because they are the once that, in the city of Parma, most exceed 
the limits allowed by law. These data were collected by the air monitoring station   
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ARPA (Regional Agency for Environmental Protection) in Montebello and made 
public , according to the Legislative Decree 195-2005 [78], on the site 
Service.arpa.emr.it/qualita-aria/bollettino.aspx?prov=pr. 
Statistical analysis  
For descriptive analysis data were summarized in terms of frequencies, of means, 
standard deviations, minimum and maximum value. 
It 'was preliminarily assessed the possible association between the dependent 
variables (spirometry tests etc.) and personal characteristics, medical history and 
clinical characteristics of the study subjects through two models, simple linear 
regression and analysis of variance. 
After dividing the concentrations of pollutants into quartiles (Q1 to Q4), was 
conducted an analysis of variance followed by a post hoc test (LSD) to identify the 
possible different distribution of average values of the dependent variables in 
quartiles of pollution. It 'was subsequently identified the fourth quartile of 
pollution (maximum values) for each pollutant considered and spirometric values 
associated with it have been tested compared to those found in the first three 
quartiles through a Student's t test for unpaired data. 
For each subject in the study were selected 2 visits corresponding to the minimum 
and maximum concentrations of pollutant considered individually. The results of 
the comparisons performed by a Student's t test for paired data were stratified by 
whether or not taking medications. 
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Through a multiple regression model, we evaluated the possible association 
between pollution and spirometric outcome adjusting for BMI and treatment. All 
statistical tests were considered significant at 0.05%. The analysis was performed 
with SPSS 20.0 statistical software. 
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RESULTS 
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Patient’s personal data were collected together with other information 
concerning BMI, atopy, smoke tendency, familiarity to asthmatic pathology and 
the therapy followed in the period of the medical examination (Table 2). It was 
evident a greater amount of female patients in regard to male patients (162 vs 
87). There was also a clear prevalence of atopic subjects: 178 compared to 71 
non-atopic subjects. Furthermore the 89% of patients are non-smokers and only 
the 17% of them was never treated with a therapy for asthma. 
The mean daily concentrations of pollutants, present the examinations days, were 
divided into quartiles (Table3). This allowed to distribute the values of the 
observations in four groups (from Q1= minimum concentration to Q4= maximum 
concentration). Depending on these concentrations the trend of the respiratory 
parameters was observed for all the examinations (n=1095). Although there aren’t 
differences statistically significant (except for FEV1/FVC in relation to NO2 with 
p=0,038) it’s of note that there was a general trend towards the decreasing of 
respiratory parameters in relation to the fourth concentration quartile (Figures 8-
13). 
Factors like atopy, sex, familiarity and the use of drugs (Table 2) could be 
considered as risk factors for the asthmatic pathology or as factors able to 
influence the respiratory functionality of patients. We have stratified the 
respiratory parameters according to these factors (Table 4-6) to evaluate their 
influence on the patient’s status. There was a statistically significant association of 
the respiratory parameters with the considered factors (Table 4-6). 
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Among all the risk factors considered, those which could be changed are therapy 
and BMI; we have evaluated the association of the respiratory parameters 
depending on the pollutants, taking also in consideration whether the patients 
were under therapy at the time of the examination or not. The evaluation was 
done with three type of analysis: 
1. Whole sample analysis in relation to the quartiles of concentration of the 
pollutants (Table 7-9); in this case the totality of the medical examinations were 
considered independently from the patients. There was a significant inverse 
association of FEV1 and FVC without therapy in relation to the increasing of the 
three pollutants considered. In the presence of a therapy there’s a significant 
negative relationship of FVC, FEV1/FVC and FEF25-75/FVC in the presence of the 
increase of NO2. 
2. Analysis of the whole patients considered as a single sample. In this case each 
patient is also control of himself because they are compared for the respiratory 
parameters recorded in two examinations in which the concentrations of the 
pollutants assume a maximum and minimum value (Table 10-12). It is observed a 
significant inverse association in the absence of the therapy for FVC both in 
relation to the maximum concentrations of NO2 and Benzene and for FEV1 in 
relation to Benzene. On the other hand the presence of the therapy reveals a 
significant negative relationship for the small airways (FEF25 and FEF25-75) and 
for FEV1 with the maximum concentrations of Benzene but only for the small 
airways (FEF25 and FEF25-75 respectively) in relation to NO2 and PM10. 
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3. Evaluation of which respiratory parameters change, in relation to the variation of 
the pollutants, with the same BMI and the presence of a therapy (Table 13). This 
analysis have underlined only a significance in relation to FeNO values. 
Finally, we have investigated, with the same three types of analysis, the variation 
of the respiratory parameters according to the various pollutants, but we have 
considered the use of or less of the steroid as therapy at the time of the 
examination: 
1. Whole sample analysis in relation to the quartiles of concentration of the 
pollutants (Table 14-16); in this case the totality of the medical examinations were 
considered independently from the patients. There was a significant negative 
association of FEV1 and FVC without steroids in relation to the increasing of the 
three pollutants considered. In the presence of the therapy there’s a significant 
inverse relationship of FEV1/FVC and FEF25-75/FVC in the presence of the 
increase of NO2. 
2. Analysis of the whole patients considered as a single sample. In this case each 
patient is also control of himself because they are compared for the respiratory 
parameters recorded in two examinations in which the concentrations of the 
pollutants assume a maximum and minimum value (Table 17-19). It is observed a 
significant negative association in the absence of the therapy for FVC both in 
relation to the maximum concentrations of NO2 and Benzene and for FEV1 in 
relation to Benzene. On the other hand the presence of the therapy reveals a 
significant inverse relationship for the small airways (FEF25) and for FEV1 with the 
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maximum concentrations of Benzene but only for the small airways (FEF25) in 
relation to NO2. 
3. Evaluation of which respiratory parameters change, in relation to the variation of 
the pollutants, with the same BMI and the presence of a therapy (Table 20). Also 
in this case the analysis have underlined only a significance in relation to FeNO 
values. 
 
 
 
 
 
 
 
 
 
 
 
 
 
52 
 
 
 
 
 
 
 
 
 
DISCUSSION 
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The study sample, consisting of 65.1% of female subjects, is representative of the 
series of patients with asthma related to the Asthma outpatient Clinic of Parma 
University Hospital relative to average age and individual characteristics such as 
BMI, family history, atopy and frequency of recruitment of drugs (Table 2). In fact, 
the selection was based on the actual residence or domicile in the metropolitan 
area of Parma and the availability of the results of spirometric tests performed in 
at least two separate occasions during the period from January 2008 and March 
2012. The average concentrations of the pollutant (PM10, NO2 and benzene), but 
decreasing in the last 10 years, amounted on average levels quite high (Table 3) 
often above the level of attention especially in winter. 
The spirometric values observed over 1095 total visits are good overall, with 
statistically significant differences between the sexes, related on familiarity and 
atopy, age and BMI. Notably females, elderly and non-atopic patients, the subject 
with familiarity and a high BMI, had spirometric values lower than males, young 
and atopic patients, subject with no familiarity and a low BMI. The subjects at the 
time of the tests are in therapy (steroids and / bronchodilators) showed  worse 
spirometric indices, particularly evident at the level of small airways. 
Analyzes for quartiles of average concentrations of pollutants showed a general 
deterioration in performance and respiratory visits that fall in the 4th quartile 
(Figures 8-13), and in particular, there was statistically significant decreases in FVC 
and FEV1 (Tables 7-9) in relation to higher values of PM10 in subjects not in 
therapy (from 103 to 98 and from 94 to 90 respectively), similar to variations 
observed in the presence of high values of NO2 (from 103 to 99 and from 94 to 90) 
and Benzene (from 103 to 98 and from 94 to 90). 
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Deepening the investigation, analysis "min-max" allowed to consider each 
individual control of himself, allowing for a more accurate estimate. Also in this 
case the data were stratified for therapy (Tables 10-12). Although not reaching 
statistical significance (except in a few cases, in particular for NO2 and Benzene), 
the spirometric tests deteriorated with respect to higher concentrations of the 
pollutant. However, if that treatment in a generic sense (any) shall be considered 
exclusively steroid therapy, are, in the analysis on quartiles, the most obvious 
changes in FVC and FEV%% for both PM10 and NO2 to that for benzene ( Tables 
14-16). Analysis min-max instead, tests on small streets seem to suffer most from 
higher values of NO2 and Benzene (Tables 17-19). 
Finally, multivariate analysis, carried out to adjust the association between 
pollution and spirometric values taking into account BMI and treatment shows 
that the NO2 values, regardless of BMI and treatment is positively correlated with 
an increase in exhaled nitric oxide (Tables 13 and 20). 
The growing interest towards the influence of environmental pollution on asthma 
led to the development of many clinical and epidemiological trials which are able 
to connect the hospital admittance due to asthma to the increase in 
environmental pollutants [28,29] and the worsening of the pathology of people 
living near high traffic areas [21]. Another interesting approach of investigation, 
although it was rarely explored in literature, was the observation of possible 
changes in respiratory parameters in relation to the variation of pollutants in a 
given period of time. This analysis was carried out also by P.C.Martins et al [24] on 
a population of asthmatic children; this allowed to set an objective association 
between the risk factor and the pathology. However the population under study 
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often didn’t present a real asthma diagnosis because the costs and the technical 
personnel required to do the diagnosis have limited widely the use of asthma in 
epidemiological trials. In this study we have taken into consideration 249 adult 
patients with an asthma diagnosis determined by the test of bronchial 
provocation with methacholine and we have also evaluated the changes in 
respiratory parameters recorded during many medical examinations. The analysis 
of their variation in relation to the increase of environmental pollutants was 
evaluated not only for the sample as a whole, which it was made in other studies, 
but also in regard to the single patient. This is the most important aspect faced in 
our research inasmuch it allowed to have a more precise assessment of the 
spirometric parameters, although the presence of many confounding factors 
made difficult to assess the weight that the environmental pollutants have on the 
variation of the respiratory functionality measured with objective trials. 
In conclusion, our results have provided the evidence that the environmental 
pollution may be an additional risk factor for the asthmatic patients. Therefore, in 
the evaluation of the asthmatic population, it is relevant to consider the 
environmental exposure of patients together with the other factors, such as sex, 
familiarity, age, BMI and atopy. 
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Figure 1: Example of particulate dimension 
 
 
 
Figure 2: Penetration capacity of the particulate in the respiratory tract. 
Human hair 50 µ 
 
Grain of sand  90 µ 
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Figure 3: Sources of Sulfur dioxide 
 
 
Figure 4: Air pollutants that affect cardio-respiratory system 
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Figure 5: the location of the lungs and airways in the body. Figure 6: a cross-
section of a normal airway. Figure 7: a cross-section of an airway during asthma 
symptoms. 
 
 
Figure 8: Changes of the ACT and FeNO in relation to quartiles of PM10 
concentrations. The analysis has been made on the entire sample of visits. 
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Figure 9: Changes of the respiratory parameters in relation to quartiles of PM10 
concentrations. The analysis has been made on the entire sample of visits. 
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Figure 10: Changes of the respiratory parameters in relation to quartiles of NO2 
concentrations. The analysis has been made on the entire sample of visits. 
73 
 
 
Figure 11: Changes of the ACT and FeNO in relation to quartiles of NO2 
concentrations. The analysis has been made on the entire sample of visits. 
 
 
 
 
Figure 12: Changes of the ACT and FeNO in relation to quartiles of Benzene 
concentrations. The analysis has been made on the entire sample of visits. 
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Figure 13: Changes of the respiratory parameters in relation to quartiles of Benzene 
concentrations. The analysis has been made on the entire sample of visits. 
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Table 1: air quality principal limits imposed by DLgs 155/10 
POLLUTANT  VALUE μg/m³ 
Sulfur dioxide Average hourly limit ≤24 
times/year 
 
350 
 Alarm threshold 3 consecutive 
hours throughout the territory 
500 
Nitrogen dioxide Ave age hourly limit ≤18  
times/year 
200 
 Alarm threshold 3 consecutive 
hours throughout the territory 
400 
 Limit annual averag  40 
PM10 Average daily limit ≤35 
times/year 
 
50 
 Li it annual average 40 
PM2,5 Limit annual average 25 
Ozone  Information threshold                     
1 hour 
180
 Alarm threshold                               
1 hour 
240
 Target value 8  consecutive 
hours ≤25 times/year 
 
120 
Carbon monoxide Limit average                                    
8 consecutive hours 
1000(= mg/m³)
Benzene  Limit annual average 5,0 
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Table 2: Descriptive of information about the sample of patients 
TOTAL SUBJECT 249 % 
SEX (M/F) 87/162 34,9/65,1 
AGE (years) 46,3 (15,7) 14-85 
BMI (Kg/m³) 24,9 (4,3) 17-40 
ATOPY (NO/YES) 71/178 28,5/71,5 
FAMILIARITY (NO/YES) 170/79 68,3/31,7 
SMOKE (NO/YES) 220/27 89,2/10,8 
THERAPY (NO/YES) 44/205 17,7/82,3 
BRONCHODILATORS 
(NO/YES) 
71/178 28,5/71,5 
STEROIDS (NO/YES) 44/205 17,7/82,3 
Dichotomous variables are expressed as frequency, continuous variables as mean, 
standard deviations and minimum and maximum values 
 
 
Table 3: Subdivision of the pollutants considered for quartiles of concentration 
 Q1 Q2 Q3 Q4 Mean        
(ds) 
 
Min-max 
 
PM10 
(μg/m3) 
≤23 
 
23,1-42,5 
 
42,6-71,2 
 
≥71,3 
 
40,8      
(24,2) 
 
9-139 
 
NO2   
(μg/m3) 
 
≤36,7 
 
36,8-50,3 
 
50,4-60,7 
 
≥60,7 
 
50 3      
(16,5) 
 
18,5-102,4 
 
Benzene 
(μg/m3) 
 
≤1,1 
 
1,2-1,8 
 
1,9-2,9 
 
≥2,9 
 
2,1          
(1,2) 
 
0,40-5,8 
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Table 4: Stratification of the respiratory parameters as a function of age and BMI 
  ETA’ BMI 
FEV1% p 0,001 0,001 
r² 0,068 0,010 
FVC% p 0,001 0,001 
r² 0,012 0,010 
FEV1/FVC% p 0,001 0,001 
r² 0,211 0,012 
FEF25% p 0,001 0,098 
r² 0,095 0,003 
FEF75% p 0,001 0,001 
r² 0,209 0,037 
FEF25-75% p 0,001 0,051 
r² 0,097 0,004 
FEF25-75/FVC p 0,001 0,006 
r² 0,212 0,007 
FeNO (ln) p 0,741 0,001 
r² 0,001 0,018 
ACT p 0,003 0,001 
r² 0,017 0,018 
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Table 5: stratification of FVC, FEV1, FEV1/FVC, FeNO e ACT, as a function of sex, familiarity, atopy 
and therapy. 
  FEV1% P FVC% P FEV1/ 
FVC% 
P FeNO 
(ln) 
P ACT P 
SEX 
M 91,14 
(16,97) 0,63 
101,16 
(17,42) 0,43 
73,49 
(9,26) 0,01 
3,47 
(0,79) 0,001 
21,74 
(3,30) 0,001 
F 89,1 
(17,27) 
100,25 
(17,98) 
74,93 
(8,76) 
3,21 
(0,85) 
20,19 
(4,49) 
FAMILIARITY 
No 91,16 
(17,27) 0,001 
101,12 
(18,05) 0,12 
75,25 
(8,76) 0,001 
3,23 
(0,82) 0,01 
20,67 
(4,33) 0,97 
YES 86,83 
(16,70) 
99,37 
(17,26) 
72,93 
(9,11) 
3,41 
(0,87) 
20,68 
(3,97) 
ATOPY 
NO 84,87 
(18,75) 0,001 
96,71 
(18,98) 0,001 
72,41 
(8,97) 0,001 
3,20 
(0,83) 0,09 
20,02 
(4,96) 0,03 
YES 91,48 
(16,26) 
101,92 
(17,16) 
75,22 
(8,82) 
3,33 
(0,85) 
20,93 
(3,86) 
THERAPY 
NO 93,131 
(16,44) 0,001 
102,34 
(16,71) 0,007 
76,191 
(8,62) 0,001 
3,46 
(0,80) 0,001 
21,702 
(3,72) 0,001 
YES 87,553 
(17,34) 
99,359 
(18,38) 
73,398 
(8,98) 
3,16 
(0,85) 
19,856 
(4,41) 
BRONCHODILATORS 
NO 93,18 
(16,51) 0,001 
102,60 
(17,25) 0,001 
76,06 
(8,16) 0,001 
3,45 
(0,79) 0,001 
21,48 
(3,70) 0,001 
YES 86,30 
(17,21) 
98,45 
(18,11) 
72,92 
(9,40) 
3,11 
(0,86) 
19,69 
(4,59) 
STEROIDS 
NO 92,81 
(16,48) 0,001 
102,06 
(16,89) 0,02 
76,11 
(8,64) 0,001 
3,47 
(0,80) 0,001 
21,61 
(3,76) 0,001 
YES 87,67 
(17,38) 
99,5 
(18,33) 
73,40 
(8,98) 
3,15 
(0,85) 
19,89 
(4,42) 
Values are expressed as mean (sd) 
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Table 6: Stratification of FEF25, FEF75, FEF25-75 e FEF25-75/FVC, as a function of sex, familiarity, 
atopy and therapy.  
  FEF25% P FEF75% P FEF25-75% P FEF25-75/  
FVC 
P 
SEX 
M 80,81 
(24,07) 0,007 
64,37 
(30,88) 0,001 
73,10 
(25,79) 0,04 
0,58      
(0,24) 0,078 
F 85,6 
(28,47) 
53,6 
(27,94) 
69,51 
(27,15) 
0,61     
(0,25) 
FAMILIARITY 
NO 86,44 
(27,39) 0,001 
59,55 
(29,94) 0,001 
73,23 
(26,68) 0,001 
0,62     
(0,25) 0,001 
YES 79,34 
(26,36) 
51,98 
(27,42) 
65,48 
(26,21) 
0,56     
(0,24) 
ATOPY 
NO 76,8 
(28,25) 0,001 
47,13 
(23,20) 0,001 
64,34 
(27,72) 0,001 
0,54     
(0,22) 0,001 
YES 86,69 
(26,40) 
60,54 
(30,47) 
72,90  
(26,06) 
0,63      
(0,25) 
THERAPY 
NO 89,175 
(28,74) 0,001 
62,941 
(30,07) 0,001 
76,213 
(26,86) 0,001 
0,65      
(0,25) 0,001 
YES 80,811 
(25,73) 
53,205 
(28,20) 
67,067 
(26,11) 
0,57      
(0,24) 
BRONCHODILATORS 
NO 89,19 
(27,77) 0,001 
62,11 
(29,34) 0,001 
75,56 
(25,74) 0,001 
0,64     
(0,24) 0,001 
YES 78,98 
(25,73) 
51,93 
(28,43) 
65,74 
(26,89) 
0,56       
(0,25) 
STEROIDS 
NO 88,6 
(28,67) 0,001 
62,67 
(30,10) 0,001 
75,94 
(26,78) 0,001 
0,65     
(0,26) 0,001 
YES 81,05 
(25,81) 
53,21 
(28,18) 
67,08   
(26,19) 
0,57     
(0,24) 
   Values are expressed as mean (sd) 
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Table 7: Changes of the respiratory parameters in relation to quartiles of PM10 concentrations. 
The analysis has been made on the entire sample of visits. 
PM10 
PARAMETERS 
RESPIRATORI 
QUARTILES THERAPY YES p THERAPY NO p 
FVC% 0 99,39 (18,41) 0,639 103,51 (16,47) 0,009  
1 100,18 (17,80) 98,50 (17,18) 
FEV1% 0 87,70 (17,21) 0,965 94,08 (15,99) 0,04   
1 87,77 (16,47) 90,19 (17,75) 
FEV1/FVC% 0 73,51 (8,90) 0,526 76,41 (8,74) 0,755 
1 72,99 (9,19) 76,98 (8,52) 
FEF25% 0 81,44 (24,79) 0,391 90,30 (28,81) 0,329 
1 79,43 (26,76) 87,06 (29,18) 
FEF75% 0 53,00 (27,58) 0,939 62,60 (29,58) 0,696 
1 53,20 (28,08) 63,96 (32,38) 
FEF25-75% 0 67,16 (25,36) 0,795 76,94 (26,81) 0,505 
1 66,54 (26,46) 74,86 (27,89) 
FEF25-75/FVC 0 0,58 (0,24) 0,378 0,66 (0,25) 0,915 
1 0,56 (0,25) 0,65 (0,25) 
FeNO (ln) 0 3,12 (0,85) 0,184 3,42 (0,78) 0,394 
1 3,26 (0,82) 3,52 (0,86) 
ACT 0 19,66 (4,36) 0,291 21,55 (3,30) 0,253 
1 20,34 (4,67) 22,24 (4,81) 
Values are expressed as mean (sd); 0=Q1-Q3, 1=Q4  
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Table 8: Changes of the respiratory parameters in relation to quartiles of NO2 concentrations. The 
analysis has been made on the entire sample of visits. 
NO₂ 
PARAMETERS 
RESPIRATORI 
QUARTILES THERAPY YES p THERAPY NO p 
FVC% 0 98,64 (18,07) 0,060  103,33 (16,63) 0,044  
1 101,76 (19,08) 99,52 (16,48) 
FEV1% 0 87,54 (17,19) 0,887 93,98 (15,71) 0,038  
1 87,76 (17,97) 90,11 (17,99) 
FEV1/FVC% 0 73,78 (9,03) 0,033  76,19 (8,63) 0,562 
1 72,05 (8,69) 75,62 (8,60) 
FEF25% 0 81,44 (25,16) 0,261 89,56 (27,58) 0,309 
1 78,80 (27,44) 86,23 (31,45) 
FEF75% 0 54,45 (28,56) 0,088 63,13 (30,46) 0,474 
1 50,05 (27,66) 60,67 (28,61) 
FEF25-75% 0 68,15 (26,13) 0,062 76,66 (26,49) 0,276 
1 63,74 (25,46) 73,32 (27,58) 
FEF25-75/FVC 0 0,59 (0,24) 0,019  0,65 (0,25) 0,716 
1 0,53 (0,23) 0,64 (0,25) 
FeNO (ln) 0 3,15 (0,89) 0,800 3,43 (0,78) 0,368 
1 3,18 (0,77) 3,54 (0,89) 
ACT 0 19,92 (4,40) 0,715 21,78 (3,21) 0,935 
1 19,69 (4,58) 21,82 (4,77) 
Values are expressed as mean (sd); 0=Q1-Q3, 1=Q4  
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Table 9: Changes of the respiratory parameters in relation to quartiles of Benzene concentrations. 
The analysis has been made on the entire sample of visits. 
BENZENE 
PARAMETERS 
RESPIRATORI 
QUARTILES THERAPY YES p THERAPY NO p 
FVC% 0 98,34 (18,53) 0,030  103,60 (16,70) 0,006  
1 101,94 (17,90) 98,37 (16,28) 
FEV1% 0 86,85 (17,45) 0,206 94,04 (16,19) 0,033  
1 88,84 (17,18) 90,01 (17,23) 
FEV1/FVC% 0 73,55 (8,67) 0,220 76,03 (8,80) 0,844 
1 72,57 (9,60) 76,23 (8,08) 
FEF25% 0 80,24 (25,20) 0,831 90,00 (28,53) 0,162 
1 80,74 (27,46) 85,38 (29,30) 
FEF75% 0 52,62 (27,78) 0,652 62,45 (28,78) 0,804 
1 53,78 (29,02) 63,31 (33,97) 
FEF25-75% 0 66,57 (25,27) 0,922 76,67 (26,38) 0,380 
1 66,34 (27,81) 73,96 (28,32) 
FEF25-75/FVC 0 0,57 (0,23) 0,359 0,65 (0,25) 0,975 
1 0,55 (0,24) 0,65 (0,24) 
FeNO (ln) 0 3,19 (0,88) 0,242 3,44 (0,77) 0,434 
1 3,07 (0,74) 3,53 (0,89) 
ACT 0 19,97 (4,45) 0,593 21,70 (3,23) 0,712 
1 19,60 (4,21) 21,93 (5,10) 
Values are expressed as mean (sd); 0=Q1-Q3, 1=Q4  
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Table 10: Changes of the respiratory parameters in relation to minimum and maximum 
concentrations of PM10 in two visits. The analysis has been made on the totality of patients as a 
sample. 
PARAMETERS THERAPY PM10 p 
MIN MAX 
FVC% Yes 101,55 (18,51) 100,78 (17,61) 0,435 
No 104,18 (17,13) 101,91 (16,10) 0,075 
FEV1% Yes 89,80 (18,31) 88,40 (16,73) 0,106 
No 94,27 (16,48) 92,55 (15,76) 0,145 
FEV1/FVC% Yes 73,59 (9,48) 73,36 (9,50) 0,653 
No 75,72 (8,77) 76,15 (8,99) 0,446 
FEF25% Yes 82,99 (26,99) 80,94 (26,03) 0,133 
No 89,18 (28,34) 87,46 (28,22) 0,318 
FEF75% Yes 55,52 (29,75) 55,23 (31,10) 0,874 
No 62,52 (31,25) 64,45 (33,78) 0,387 
FEF25-75% Yes 69,77 (28,39) 66,84 (26,89) 0,049 
No 75,94 (26,94) 75,98 (28,11) 0,984 
FEF25-75/FVC Yes 0,59 (0,25) 0,58 (0,27) 0,410 
No 0,64 (0,24) 0,65 (0,26) 0,338 
FeNO (ln) Yes 3,03 (0,84) 3,06 (0,78) 0,773 
No 3,53 (0,79) 3,64 (0,89) 0,255 
ACT Yes 19,72 (4,69) 20,94 (4,05) 0,122 
No 22,02 (3,20) 22,33 (4,88) 0,735 
Values are expressed as mean (sd) 
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Table 11: Changes of the respiratory parameters in relation to minimum and maximum 
concentrations of NO2 in two visits. The analysis has been made on the totality of patients as a 
sample. 
PARAMETERS     THERAPY NO₂         p           
p 
MIN  MAX 
FVC% Yes 100,73 (17,99) 100,38 (18,01) 0,751 
No 104,87 (17,16) 102,22 (17,16) 0,045 
FEV1% Yes 89,09 (18,22) 87,88 (17,06) 0,193 
No 94,07 (17,45) 92,82 (16,21) 0,265 
FEV1/FVC% Yes 73,52 (9,75) 73,03 (9,43) 0,382 
No 75,39 (9,03) 75,85 (8,93) 0,455 
FEF25% Yes 82,72 (28,02) 79,56 (25,19) 0,017 
No 88,06 (28,52) 87,73 (27,22) 0,826 
FEF75% Yes 54,10 (29,64) 54,35 (31,09) 0,896 
No 60,97 (30,08) 62,92 (33,12) 0,337 
FEF25-75% Yes 68,76 (68,76) 66,04 (26,53) 0,093 
No 74,73 (27,56) 75,68 (26,73) 0,573 
FEF25-75/FVC Yes 0,58 (0,26) 0,56 (0,24) 0,160 
No 0,62 (0,25) 0,65 (0,25) 0,076 
FeNO (ln) Yes 2,96 (0,84) 3,06 (0,80) 0,215 
No 3,47 (0,84) 3,57 (0,87) 0,330 
ACT Yes 19,61 (4,31) 18,91 (5,04) 0,401 
No 22,61 (2,69) 22,68 (4,88) 0,933 
Values are expressed as mean (sd) 
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Table 12: Changes of the respiratory parameters in relation to minimum and maximum 
concentrations of Benzene in two visits. The analysis has been made on the totality of patients as a 
sample 
PARAMETERS     THERAPY BENZENE       p             
p 
MIN  MAX 
FVC% Yes 101,70 (17,44) 99,98 (19,11) 0,136 
No 105,90 (16,35) 101,19 (16,73) 0,001 
FEV1% Yes 89,86 (17,57) 87,66 (17,04) 0,012 
No 94,74 (16,70) 91,87 (16,46) 0,009 
FEV1/FVC% Yes 73,65 (9,64) 72,99 (9,32) 0,213 
No 75,41 (8,72) 75,92 (8,76) 0,340 
FEF25% Yes 83,59 (27,30) 79,74 (26,37) 0,008 
No 88,29 (29,03) 86,41 (27,61) 0,215 
FEF75% Yes 54,12 (27,88) 54,16 (28,61) 0,982 
No 60,66 (29,33) 63,06 (33,38) 0,230 
FEF25-75% Yes 68,95 (27,41) 65,58 (26,06) 0,043 
No 74,97 (27,23) 74,98 (27,04) 0,996 
FEF25-75/FVC Yes 0,58 (0,25) 0,56 (0,26) 0,20 
No 0,62 (0,24) 0,64 (0,25) 0,201 
FeNO (ln) Yes 3,13 (0,89) 3,13 (0,79) 0,987 
No 3,41 (0,84) 3,55 (0,89) 0,214 
ACT Yes 20,50 (3,60) 20,44 (4,33) 0,940 
No 22,59 (2,69) 22,86 (4,88) 0,767 
Values are expressed as mean (sd) 
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Table 13: Changes of respiratory parameters in relation to the pollutants concentrations, on equal 
BMI and assumption of therapy.  
PARAMETERS  PM10  
(beta) 
p NO2    
(beta) 
p BENZENE 
(beta) 
p 
FVC% -0,036 0,237 0,031 0,312 -0,010 0,741 
FEV1% -0,050 0,104 0,006 0,850 -0,015 0,624 
FEV1/FVC% -0,035 0,255 -0,039 0,195 -0,033 0,274 
FEF25% -0,054 0,080 -0,019 0,543 -0,026 0,402 
FEF75% 0,011 0,719 0,008 0,803 -0,025 0,403 
FEF25-75% -0,032 0,292 -0,014 0,646 -0,014 0,650 
FEF25-75/FVC -0,027 0,372 -0,037 0,222 -0,034 0,263 
FeNO (ln) 0,045 0,264 0,087 0,031 0,058 0,150 
ACT 0,024 0,587 0,035 0,417 0,045 0,304 
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Table 14: Changes of the respiratory parameters in relation to quartiles of PM10 concentrations. 
The analysis has been made on the entire sample of visits. 
PM10 
PARAMETERS 
RESPIRATORI 
QUARTILES STEROIDS YES p STEROIDS NO p 
FVC% 0 99,41 (18,44) 0,434 103,37 (16,50) 0,003  
1 100,73 (17,43) 97,74 (17,65) 
FEV1% 0 87,71 (17,33) 0,723 93,89 (15,87) 0,016  
1 88,27 (16,24) 89,40 (18,11) 
FEV1/FVC% 0 73,53 (8,94) 0,457 76,29 (8,69) 0,861 
1 72,91 (9,02) 76,11 (8,77) 
FEF25% 0 81,62 (24,91) 0,470 89,78 (28,67) 0,268 
1 79,90 (26,76) 86,17 (29,30) 
FEF75% 0 53,07 (27,77) 0,973 62,22 (29,32) 0,611 
1 52,99 (27,32) 63,96 (33,14) 
FEF25-75% 0 67,13 (25,49) 0,861 76,70 (26,61) 0,448 
1 66,71 (26,35) 74,39 (28,11) 
FEF25-75/FVC 0 0,58 (0,24) 0,214 0,65 (0,25) 0,789 
1 0,55 (0,23) 0,66 (0,28) 
FeNO (ln) 0 3,11 (0,85) 0,206 3,42 (0,78) 0,349 
1 3,25 (0,81) 3,54 (0,86) 
ACT 0 19,66 (4,38) 0,205 21,50 (3,31) 0,405 
1 20,49 (4,62) 21,99 (4,93) 
Values are expressed as mean (sd); 0=Q1-Q3, 1=Q4  
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Table 15: Changes of the respiratory parameters in relation to quartiles of NO2 concentrations. The 
analysis has been made on the entire sample of visits. 
NO₂ 
PARAMETERS QUARTILES STEROIDS YES p STEROIDS NO p 
FVC% 0 98,70 (18,12) 0,038   103,12 (16,62) 0,029   
1 102,17 (18,68) 99,01 (17,17) 
FEV1% 0 87,58 (17,32) 0,746 93,74 (15,60) 0,021   
1 88,10 (17,76) 89,52 (18,35) 
FEV1/FVC% 0 73,81 (9,07) 0,024  76,09 (8,59) 0,633 
1 71,96 (8,53) 75,63 (8,81) 
FEF25% 0 81,68 (25,29) 0,266 88,99 (27,47) 0,294 
1 79,03 (27,42) 85,62 (31,44) 
FEF75% 0 54,53 (28,73) 0,071 62,80 (30,23) 0,517 
1 49,82 (26,97) 60,61 (29,49) 
FEF25-75% 0 68,15 (26,25) 0,068 76,45 (26,34) 0,240 
1 63,76 (25,41) 72,92 (27,66) 
FEF25-75/FVC 0 0,59 (0,24) 0,006  0,64 (0,25) 0,978 
1 0,53 (0,21) 0,64 (0,28) 
FeNO (ln) 0  3,14 (0,89) 0,954 3,44 (0,78) 0,273 
1 3,15 (0,76) 3,56 (0,89) 
ACT 0 19,94 (4,41) 0,776 21,71 (3,24) 0,923 
1 19,76 (4,57) 21,65 (4,82) 
Values are expressed as mean (sd); 0=Q1-Q3, 1=Q4  
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Table 16: Changes of the respiratory parameters in relation to quartiles of NO2 concentrations. The 
analysis has been made on the entire sample of visits. 
BENZENE 
PARAMETERS QUARTILES STEROIDS YES p STEROIDS NO p 
FVC% 0 98,26 (18,56) 0,011   103,60 (16,68) 0,002  
1 102,50 (17,49) 97,60 (16,81) 
FEV1% 0 86,82 (17,53) 0,113 93,93 (16,09) 0,011  
1 89,33 (16,94) 89,20 (17,61) 
FEV1/FVC% 0 73,59 (8,70) 0,174 75,92 (8,77) 0,744 
1 72,49 (9,46) 76,24 (8,36) 
FEF25% 0 80,34 (25,28) 0,711 89,64 (28,44) 0,115 
1 81,22 (27,45) 84,51 (29,37) 
FEF75% 0 52,72 (27,92) 0,738 62,09 (28,64) 0,717 
1 53,59 (28,34) 63,33 (34,67) 
FEF25-75% 0 66,60 (25,38) 0,964 76,40 (26,27) 0,340 
1 66,49 (27,73) 73,50 (28,51) 
FEF25-75/FVC 0 0,58 (0,23) 0,199 0,64 (0,25) 0,735 
1 0,55 (0,23) 0,65 (0,27) 
FeNO (ln) 0 3,19 (0,88) 0,194 3,44 (0,77) 0,380 
1 3,04 (0,73) 3,55 (0,89) 
ACT 0 19,98 (4,48) 0,758 21,65 (3,25) 0,953 
1 19,76 (4,15) 21,68 (5,20) 
Values are expressed as mean (sd); 0=Q1-Q3, 1=Q4  
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Table 17: Changes of the respiratory parameters in relation to minimum and maximum 
concentrations of PM10  in two visits. The analysis has been made on the totality of patients as a 
sample. 
PARAMETERS     STEROIDS PM10       p             
p 
MIN  MAX 
FVC% Yes 101,26 (18,43) 100,61 (17,52) 0,523 
No 103,68 (17,99) 101,26 (16,85) 0,109 
FEV1% Yes 89,54 (18,33) 88,67 (16,65) 0,286 
No 93,81 (16,81) 91,94 (16,28) 0,165 
FEV1/FVC% Yes 73,55 (9,61) 73,61 (9,51) 0,907 
No 75,78 (9,03) 76,14 (9,24) 0,524 
FEF25% Yes 82,90 (27,22) 81,40 (25,99) 0,272 
No 88,11 (28,16) 86,52 (28,19) 0,385 
FEF75% Yes 55,74 (30,15) 56,18 (30,81) 0,804 
No 62,63 (31,28) 64,77 (34,32) 0,337 
FEF25-75% Yes 69,60 (28,53) 67,74 (26,86) 0,178 
No 75,61 (26,66) 75,90 (28,28) 0,879 
FEF25-75/FVC Yes 0,59 (0,26) 0,58 (0,26) 0,735 
No 0,64 (0,25) 0,66 (0,29) 0,265 
FeNO (ln) Yes 3,11 (0,84) 3,09 (0,78) 0,894 
No 3,56 (0,80) 3,60 (0,88) 0,601 
ACT Yes 19,74 (4,70) 20,64 (4,49) 0,304 
No 22,05 (3,23) 22,10 (3,04) 0,939 
Values are expressed as mean (sd) 
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Table 18: Changes of the respiratory parameters in relation to minimum and maximum 
concentrations of NO2 in two visits. The analysis has been made on the totality of patients as a 
sample. 
PARAMETERS     STEROIDS NO₂       p             
p 
MIN  MAX 
FVC% Yes 100,75 (18,21) 100,99 (17,77) 0,833 
No 104,37 (18,12) 101,79 (17,60)  0,045    
FEV1% Yes 89,19 (18,30) 88,52 (17,14) 0,467 
No 93,62 (17,63) 92,16 (16,44) 0,178 
FEV1/FVC% Yes 73,55 (9,74 ) 73,04 (9,31) 0,347 
No 75,43 (9,16) 75,64 (9,24) 0,718 
FEF25% Yes 83,12 (28,07) 80,42 (25,45)  0,046 
No 87,20 (28,52) 86,77 (27,26) 0,763 
FEF75% Yes 54,33 (29,65) 54,46 (30,67) 0,942 
No 60,80 (29,70) 62,69 (33,38) 0,340 
FEF25-75% Yes 68,93 (28,31) 66,79 (26,98) 0,175 
No 74,57 (27,14) 75,15 (26,73) 0,724 
FEF25-75/FVC Yes 0,58 (0,26) 0,56 (0,24) 0,160 
No 0,62 (0,25) 0,65 (0,28) 0,092 
FeNO (ln) Yes 2,98 (0,83) 3,06 (0,81) 0,330 
No 3,48 (0,83) 3,58 (0,87) 0,310 
ACT Yes 19,19 (4,62) 18,87 (5,12) 0,700 
No 22,64 (2,66) 22,69 (4,81) 0,957 
Values are expressed as mean (sd) 
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Table 19: Changes of the respiratory parameters in relation to minimum and maximum 
concentrations of NO2 in two visits. The analysis has been made on the totality of patients as a 
sample. 
PARAMETERS     STEROIDS BENZENE         p           
p 
MIN  MAX 
FVC% Yes 101,99 (17,62) 100,38 (19,27) 0,161 
No 105,18 (17,45) 101,23 (16,93)  0,001 
FEV1% Yes 90,09 (17,64) 88,16 (17,27)  0,023 
No 94,08 (17,10) 91,60 (16,72)  0,023 
FEV1/FVC% Yes 73,62 (9,68) 73,11 (9,34) 0,329 
No 75,47 (8,97) 75,78 (9,12) 0,550 
FEF25% Yes 84,00 (27,38) 80,30 (26,61)  0,010 
No 87,76 (29,34) 85,92 (27,77) 0,223 
FEF75% Yes 54,32 (27,89) 54,75 (28,26) 0,787 
No 60,95 (29,24) 63,35 (33,87) 0,233 
FEF25-75% Yes 69,15 (27,37) 66,39 (26,50) 0,090 
No 74,74 (27,12) 74,80 (27,17) 0,971 
FEF25-75/FVC Yes 0,58 (0,25) 0,57 (0,25) 0,264 
No 0,62 (0,02) 0,64 (0,28) 0,204 
FeNO (ln) Yes 3,15 (0,87) 3,13 (0,80) 0,826 
No 3,44 (0,84) 3,56 (0,87) 0,265 
ACT Yes 20,12 (4,03) 20,45 (4,39) 0,661 
No 22,64 (2,63) 22,87 (4,75) 0,790 
Values are expressed as mean (sd) 
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Table 20: Changes of respiratory parameters in relation to the pollutants concentrations, on equal 
BMI and assumption of steroid. 
PARAMETERS PM10 p NO2 p BENZENE p 
FVC% -0,037 0,236 0,031 0,316 -0,010 0,734 
FEV1% -0,050 0,103 0,005 0,862 -0,015 0,612 
FEV1/FVC% -0,035 0,251 -0,040 0,189 -0,034 0,268 
FEF25% -0,054 0,079 -0,019 0,536 -0,026 0,394 
FEF75% 0,011 0,727 0,007 0,816 0,025 0,410 
FEF25-75% -0,033 0,287 -0,015 0,633 -0,014 0,640 
FEF25-75/FVC -0,028 0,367 -0,038 0,215 -0,034 0,259 
FeNO (ln) 0,045 0,259 0,088 0,029 0,058 0,147 
ACT 0,024 0,588 0,036 0,410 0,045 0,307 
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